The start-up, based in San Francisco, leverages its platform to assist users in streamlining communication with doctors and insurance providers to obtain their prescribed medications. Initially established as ScriptDash in 2015, the company underwent a rebranding in 2017 after securing $23 million in funding from investors like Greenoaks Capital and Jackson Square Ventures. Alto further achieved notable financial milestones, accumulating $20 million through series B funding in 2017, $50 million through series C funding in 2018, and a substantial $250 million through series D funding in 2020. These successful funding rounds cumulatively raised Alto's total investment to over $350 million.
$5.4M • 2019 • Seed
Alto is driven by the mission to prioritize accessibility and convenience in healthcare through its telehealth pharmacy services, while steadfastly upholding affordability as a fundamental value.
Winning pitch decks that have closed millions in investments for leading startups and billion-dollar unicorns.
Investors see 5,000 pitch decks per year. Will you stand out?
No spam. Up to 2 emails/mo – only the good stuff!